Skip to content
Review Open access

Ten tips for the diagnosis and management of nephrotic syndrome

Aug 2026 · Clinical Kidney Journal · Vol 19 · 0 citations · 90 references
Medicine

TL;DR

Ten practical tips to improve clinical decision-making in the diagnosis and management of Nephrotic syndrome are presented to help increase awareness of common pitfalls and support more attentive clinical management of patients with NS.

Abstract

ABSTRACT Nephrotic syndrome (NS) encompasses a heterogeneous group of glomerular diseases characterized by heavy proteinuria, hypoalbuminemia, edema, and multiple systemic complications. Despite substantial advances in diagnostic techniques and targeted therapies, the management of NS remains challenging in clinical practice. In addition to complex treatment decisions, clinicians must address diagnostic uncertainty, recognize secondary causes, and prevent potentially serious complications including thrombosis, infections, cardiovascular disease, and progressive kidney dysfunction. Adverse outcomes in NS frequently arise not only from inappropriate management but also from overlooked steps in diagnosis, monitoring, and long-term care. Here, we present 10 practical tips to improve clinical decision-making in the diagnosis and management of NS. Key positive strategies include appropriate use of kidney biopsy and modern immunopathologic techniques, integration of immunologic biomarkers such as anti-phospholipase A2 receptor antibodies in the evaluation of membranous nephropathy, systematic exclusion of secondary causes, and comprehensive supportive care including blood pressure control, antiproteinuric therapy, and thrombosis prophylaxis in high-risk patients. In addition, evidence-based use of immunosuppressive therapies (IST) tailored to specific disease entities is emphasized. Equally important are commonly overlooked pitfalls that may compromise outcomes, including delayed genetic testing in steroid-resistant disease, prolonged ineffective immunosuppression, inadequate post-transplant surveillance for recurrence, under-recognition of cardiovascular risk, and failure to prevent complications associated with IST. Highlighting these practical considerations may help increase awareness of common pitfalls and support more attentive clinical management of patients with NS.

Read PDF

Similar papers

Open access Sep 2026

Unmet Needs in the Management of Adult Patients with Lupus Nephritis.

A perspective of the Immunonephrology Working Group (IWG) of the European Renal Association (ERA) is provided and discusses the key unmet needs in the management of lupus nephritis.

Ş. Özcan, A. Bruchfeld, F. Caravaca-Fontán et al. · 0 citations
Review Open access Sep 2026

Complement diagnostics and therapeutics for the pediatric population: early successes and opportunities for further advancement

Complement-mediated diseases are individually rare, often rapidly progressive, and historically associated with high rates of permanent organ injury or death but are now among the most therapeutically actionable conditions in pediatric nephrology, hematology, and rheumatology. As demonstrated by thrombotic microangiopa...

Russell Whelan, Bradley P. Dixon · 0 citations
Open access Sep 2026

Clinical heterogeneity in biopsy-proven adult focal segmental glomerulosclerosis

Focal segmental glomerulosclerosis (FSGS) is a histopathological pattern of podocyte injury and a major cause of nephrotic syndrome in adults. Despite a common histopathological diagnosis, patients may exhibit considerable variability in clinical presentation, disease severity, therapeutic response, and renal outcomes....

Kazi Ammara, AA Khan, Malhar Lonikar et al. · 0 citations
Open access Sep 2026

Value of Repeat Renal Biopsy in Lupus Nephritis: Histological Transitions, Treatment Impact, and Predictors of Repeat Biopsy and Active Disease.

A longer SLE duration predicted the need for repeat renal biopsy, and a baseline proliferative LN strongly predicts active disease on re-biopsy, and repeat renal biopsy remains an indispensable tool for optimizing individualized immunosuppressive therapy.

M. Bedaiwi, Najma Khalil, I. Almaghlouth et al. · 0 citations
Review Open access Oct 2026

Congenital Nephrotic Syndrome: Etiology, Clinical Presentation, and a Comparison of Optimal Treatment Strategies – A Literature Review

Introduction: Congenital nephrotic syndrome is a rare condition with symptom onset occurring within the first three months of life. It affects approximately 1 to 3 per 100,000 live births. It has a varied etiology on a genetic, non-genetic, and infectious basis. While management primarily relies on symptomatic care, ad...

Antonina Gendasz, Julia Tesyna, Aleksandra Obszańska et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.